ClinicalTrials.govpublic full text
Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplant
stem cell transplantation, hematopoietic, mesenchymal stem cells, poor graft function, hematological diseases, allogeneic hematopoietic stem cell transplantation, third-party donors, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 836702
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.